617
Views
29
CrossRef citations to date
0
Altmetric
Reviews

Activation of 5-hydroxytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs

, , &
Pages 1599-1610 | Published online: 02 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Abimael González-Hernández, Bruno A. Marichal-Cancino, Antoinette MaassenVanDenBrink & Carlos M. Villalón. (2018) Side effects associated with current and prospective antimigraine pharmacotherapies. Expert Opinion on Drug Metabolism & Toxicology 14:1, pages 25-41.
Read now
Piero Barbanti, C. Aurilia, G. Egeo, L. Fofi & R. Palmirotta. (2017) Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical development. Expert Opinion on Investigational Drugs 26:3, pages 269-277.
Read now
Luana Lionetto, Marina Borro, Martina Curto, Matilde Capi, Andrea Negro, Fabiola Cipolla, Giovanna Gentile & Paolo Martelletti. (2016) Choosing the safest acute therapy during chronic migraine prophylactic treatment: pharmacokinetic and pharmacodynamic considerations. Expert Opinion on Drug Metabolism & Toxicology 12:4, pages 399-406.
Read now

Articles from other publishers (26)

Nikhil R. Tasker, Ethan J. Pazur & Peter Wipf. (2023) Biological studies of clavine alkaloids targeting CNS receptors. Frontiers in Psychiatry 14.
Crossref
Raghavendra Ramachanderan, Stefan Schramm & Bernd Schaefer. (2023) Migraine drugs. ChemTexts 9:2.
Crossref
Vern Lewis, Emma M. Bonniwell, Janelle K. Lanham, Abdi Ghaffari, Hooshmand Sheshbaradaran, Andrew B. Cao, Maggie M. Calkins, Mario Alberto Bautista-Carro, Emily Arsenault, Andre Telfer, Fatimeh-Frouh Taghavi-Abkuh, Nicholas J. Malcolm, Fatema El Sayegh, Alfonso Abizaid, Yasmin Schmid, Kathleen Morton, Adam L. Halberstadt, Argel Aguilar-Valles & John D. McCorvy. (2023) A non-hallucinogenic LSD analog with therapeutic potential for mood disorders. Cell Reports 42:3, pages 112203.
Crossref
Simona Sacco, Christian Lampl, Faisal Mohammad Amin, Mark Braschinsky, Christina Deligianni, Derya Uludüz, Jan Versijpt, Anne Ducros, Raquel Gil-Gouveia, Zaza Katsarava, Paolo Martelletti, Raffaele Ornello, Bianca Raffaelli, Deirdre M. Boucherie, Patricia Pozo-Rosich, Margarita Sanchez-del-Rio, Alexandra Sinclair, Antoinette Maassen van den Brink & Uwe Reuter. (2022) European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure. The Journal of Headache and Pain 23:1.
Crossref
Ying Chen, Yuhan Liu, Yine Song, Shaoru Zhao, Bin Li, Jingqing Sun & Lu Liu. (2022) Therapeutic applications and potential mechanisms of acupuncture in migraine: A literature review and perspectives. Frontiers in Neuroscience 16.
Crossref
Brian Johnson & Frederick G. Freitag. (2022) New Approaches to Shifting the Migraine Treatment Paradigm. Frontiers in Pain Research 3.
Crossref
Irina I. Belyaeva, Anna G. Subbotina, Ivan I. Eremenko, Vadim V. Tarasov, Vladimir N. Chubarev, Helgi B. Schiöth & Jessica Mwinyi. (2022) Pharmacogenetics in Primary Headache Disorders. Frontiers in Pharmacology 12.
Crossref
Moein Ala, Mehdi Ghasemi, Razieh Mohammad Jafari & Ahmad Reza Dehpour. (2021) Beyond its anti‐migraine properties, sumatriptan is an anti‐inflammatory agent: A systematic review . Drug Development Research 82:7, pages 896-906.
Crossref
Xinna Wang, Hongfei Zhao, Liming Liu, Ping Niu, Chao Zhai, Jinjian Li, Qiaoli Xu & Dexi Zhao. (2020) Hejie Zhitong prescription promotes sleep and inhibits nociceptive transmission-associated neurotransmitter activity in a rodent migraine model. Chinese Medicine 15:1.
Crossref
Chunhua Tang, Miyuki Unekawa, Satoshi Kitagawa, Tsubasa Takizawa, Yohei Kayama, Jin Nakahara & Mamoru Shibata. (2020) Cortical spreading depolarisation-induced facial hyperalgesia, photophobia and hypomotility are ameliorated by sumatriptan and olcegepant. Scientific Reports 10:1.
Crossref
Swapnil Raut, Upasna Singh, Deepaneeta Sarmah, Aishika Datta, Falguni Baidya, Birva Shah, Mariya Bohra, Priya Jagtap, Ankan Sarkar, Kiran Kalia, Anupom Borah, Kunjan R. Dave, Dileep R. Yavagal & Pallab Bhattacharya. (2020) Migraine and Ischemic Stroke: Deciphering the Bidirectional Pathway. ACS Chemical Neuroscience 11:11, pages 1525-1538.
Crossref
Claire E. J. Ceriani, Danielle A. Wilhour & Stephen D. Silberstein. (2019) Novel Medications for the Treatment of Migraine. Headache: The Journal of Head and Face Pain 59:9, pages 1597-1608.
Crossref
Pei Pei, Lu Liu, Luo-Peng Zhao, Zheng-Yang Qu, Chu-Ying Tang, Lin-Peng Wang & Wenming Yang. (2019) Electroacupuncture exerts an anti-migraine effect via modulation of the 5-HT7 receptor in the conscious rat. Acupuncture in Medicine 37:1, pages 47-54.
Crossref
Guillemette Fouquet, Tereza Coman, Olivier Hermine & Francine Côté. (2019) Serotonin, hematopoiesis and stem cells. Pharmacological Research 140, pages 67-74.
Crossref
Marta Vila-Pueyo. (2018) Targeted 5-HT1F Therapies for Migraine. Neurotherapeutics 15:2, pages 291-303.
Crossref
José X. Lima Neto, Vanessa P. Soares-Rachetti, Eudenilson L. Albuquerque, Vinicius Manzoni & Umberto L. Fulco. (2018) Outlining migrainous through dihydroergotamine–serotonin receptor interactions using quantum biochemistry. New Journal of Chemistry 42:4, pages 2401-2412.
Crossref
Stephen D. Silberstein. (2018) Current management: migraine headache. CNS Spectrums 22:S1, pages 1-13.
Crossref
Ronald G. Garcia, Richard L. Lin, Jeungchan Lee, Jieun Kim, Riccardo Barbieri, Roberta Sclocco, Ajay D. Wasan, Robert R. Edwards, Bruce R. Rosen, Nouchine Hadjikhani & Vitaly Napadow. (2017) Modulation of brainstem activity and connectivity by respiratory-gated auricular vagal afferent nerve stimulation in migraine patients. Pain 158:8, pages 1461-1472.
Crossref
Jingbo SunHe LiJinghui SunHuimin LiuJianguang ChenChunmei Wang. (2017) Chemical Composition and Antimigraine Activity of Essential Oil of Angelicae dahuricae Radix . Journal of Medicinal Food 20:8, pages 797-803.
Crossref
Purificación Magán Tapia, Marta Teresa Escuredo Bergua & Silvia Estrada de la Viuda. (2017) Tratamiento de la migraña aguda y crónica y aspectos preventivos. FMC - Formación Médica Continuada en Atención Primaria 24:3, pages 157-165.
Crossref
Pei Pei, Lu Liu, Luopeng Zhao, Yingxue Cui, Zhengyang Qu & Linpeng Wang. (2016) Effect of Electroacupuncture Pretreatment at Gb20 on Behaviour and the Descending Pain Modulatory System in a Rat Model of Migraine. Acupuncture in Medicine 34:2, pages 127-135.
Crossref
John D. Chan, Prince N. Agbedanu, Thomas Grab, Mostafa Zamanian, Peter I. Dosa, Timothy A. Day & Jonathan S. Marchant. (2015) Ergot Alkaloids (Re)generate New Leads as Antiparasitics. PLOS Neglected Tropical Diseases 9:9, pages e0004063.
Crossref
John D. McCorvy & Bryan L. Roth. (2015) Structure and function of serotonin G protein-coupled receptors. Pharmacology & Therapeutics 150, pages 129-142.
Crossref
Gang Yao, Ximei Han, Tingting Hao, Qian Huang & Tingmin Yu. (2015) Effects of rizatriptan on the expression of calcitonin gene-related peptide and cholecystokinin in the periaqueductal gray of a rat migraine model. Neuroscience Letters 587, pages 29-34.
Crossref
Maria Martí-Solano, Ferran Sanz, Manuel Pastor & Jana Selent. (2014) A Dynamic View of Molecular Switch Behavior at Serotonin Receptors: Implications for Functional Selectivity. PLoS ONE 9:10, pages e109312.
Crossref
Paul Edward Rolan. (2014) Understanding the pharmacology of headache. Current Opinion in Pharmacology 14, pages 30-33.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.